Kaniecki T, Hughes M, McMahan Z
Expert Rev Clin Immunol. 2024; 20(6):603-622.
PMID: 38406978
PMC: 11098704.
DOI: 10.1080/1744666X.2024.2320205.
Zhu S, Xu M, Wang H, Pan H, Wang G, Huang M
BMC Genomics. 2018; 19(1):411.
PMID: 29843600
PMC: 5975492.
DOI: 10.1186/s12864-018-4813-8.
Leiman D, Riff B, Morgan S, Metz D, Falk G, French B
Dis Esophagus. 2017; 30(5):1-9.
PMID: 28375448
PMC: 6036656.
DOI: 10.1093/dote/dow020.
Pouchain D, Bigard M, Liard F, Childs M, Decaudin A, McVey D
BMC Gastroenterol. 2012; 12:18.
PMID: 22361121
PMC: 3298711.
DOI: 10.1186/1471-230X-12-18.
Banks M
Clin Med (Lond). 2010; 9(6):600-4.
PMID: 20095310
PMC: 4952306.
DOI: 10.7861/clinmedicine.9-6-600.
Antacids. Indications and limitations.
Ching C, Lam S
Drugs. 1994; 47(2):305-17.
PMID: 7512903
DOI: 10.2165/00003495-199447020-00006.
Evaluation of elevation of the head of the bed, bethanechol, and antacid form tablets on gastroesophageal reflux.
Johnson L, DeMeester T
Dig Dis Sci. 1981; 26(8):673-80.
PMID: 7261830
DOI: 10.1007/BF01316854.
Comparison of the combination of cholestyramine/alginates with placebo in the treatment of postgastrectomy biliary reflux gastritis.
Nicolai J, Speelman P, Tytgat G, van der Stadt J
Eur J Clin Pharmacol. 1981; 21(3):189-94.
PMID: 7032948
DOI: 10.1007/BF00627919.
Current approaches in the medical treatment of oesophageal reflux.
Richter J, Castell D
Drugs. 1981; 21(4):283-91.
PMID: 7014172
DOI: 10.2165/00003495-198121040-00004.
Comparative study of four antacids.
Jacyna M, Boyd E, Wormsley K
Postgrad Med J. 1984; 60(707):592-6.
PMID: 6091079
PMC: 2417996.
DOI: 10.1136/pgmj.60.707.592.
[Applications of endoscopy, manometry, and conservative therapy (author's transl)].
Wienbeck M
Langenbecks Arch Chir. 1974; 337:103-8.
PMID: 4449307
DOI: 10.1007/BF01278641.
Medical management of heartburn.
Br Med J. 1974; 4(5936):64-5.
PMID: 4414623
PMC: 1612192.
Reproducibility of ambulatory oesophageal pH monitoring.
Johnsson F, Joelsson B
Gut. 1988; 29(7):886-9.
PMID: 3396963
PMC: 1433777.
DOI: 10.1136/gut.29.7.886.
24-hour esophageal pH monitoring before and after medical therapy for reflux esophagitis.
Lieberman D
Dig Dis Sci. 1988; 33(2):166-71.
PMID: 3338365
DOI: 10.1007/BF01535728.
Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children.
Buts J, Barudi C, Otte J
Eur J Pediatr. 1987; 146(2):156-8.
PMID: 3032640
DOI: 10.1007/BF02343223.
Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis.
Smart H, Atkinson M
J R Soc Med. 1990; 83(9):554-6.
PMID: 2213800
PMC: 1292812.
DOI: 10.1177/014107689008300907.
Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux.
Greally P, Hampton F, MacFadyen U, Simpson H
Arch Dis Child. 1992; 67(5):618-21.
PMID: 1599300
PMC: 1793694.
DOI: 10.1136/adc.67.5.618.
Alginic acid decreases postprandial upright gastroesophageal reflux. Comparison with equal-strength antacid.
Castell D, Dalton C, Becker D, Sinclair J, Castell J
Dig Dis Sci. 1992; 37(4):589-93.
PMID: 1551350
DOI: 10.1007/BF01307584.
Vestibular reactions associated with minocycline.
Jacobson J, Daniel B
Antimicrob Agents Chemother. 1975; 8(4):453-6.
PMID: 1081373
PMC: 429369.
DOI: 10.1128/AAC.8.4.453.
Carbenoxolone: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.
Pinder R, Brogden R, SAWYER P, Speight T, Spencer R, Avery G
Drugs. 1976; 11(4):245-307.
PMID: 780088
DOI: 10.2165/00003495-197611040-00002.
